US6890708B2ExpiredUtilityA1
Method for improving the quality of sperm for artificial insemination of animals
Assignee: ID LELYSTAD INST DIERHOUDERIJPriority: Apr 20, 2000Filed: Oct 21, 2002Granted: May 10, 2005
Est. expiryApr 20, 2020(expired)· nominal 20-yr term from priority
A61K 31/522A61K 35/52Y10S604/906
65
PatentIndex Score
6
Cited by
10
References
16
Claims
Abstract
A method and composition for artificial insemination. The method involves artificially inseminating the subject with sperm, wherein the sperm is combined or coadministered with an inhibitor of phosphodiesterase and preferably a soluble salt of an earth alkaline metal. The composition comprises phosphodiesterase inhibitor or a functional equivalent thereof, a soluble salt of an earth alkaline metal and sperm. The method and composition reduce the recruitment of polymorphonuclear neutrophils.
Claims
exact text as granted — not AI-modified1. A method for artificially inseminating a subject, said method comprising:
obtaining sperm;
obtaining a composition comprising an inhibitor of phosphodiesterase and a calcium salt;
mixing said sperm with said composition, thus producing an inseminate; and
administering the inseminate to the subject.
2. The method according to claim 1 , wherein the inhibitor of phosphodiesterase is selected from the group consisting of caffeine, theophylline, theobromine, isobutylmethylxanthine, other xanthine based compounds, papaverine, and combinations of any thereof.
3. The method according to claim 1 , wherein an amount of the inhibitor of phosphodiesterase comprises up to 10 mmol per liter of said inseminate.
4. The method according to claim 1 , wherein a concentration of the calcium salt comprises up to 10 mmol per liter of said inseminate.
5. The method according to claim 1 , wherein:
the calcium salt comprises calcium chloride; and
a concentration of the calcium chloride comprises an amount of about 0.1 to 8 mmol per liter of said inseminate.
6. The method according to claim 1 , wherein the subject is a mammal or a bird.
7. The method according to claim 5 , wherein the subject is a pig.
8. A method for reducing phagocytosis of sperm in a female genital tract, said method comprising:
obtaining sperm;
obtaining a solution comprising an inhibitor of phosphodiesterase and a calcium salt;
admixing said sperm with said solution for inseminating a subject.
9. The method according to claim 8 , wherein the inhibitor of phosphodiesterase is caffeine.
10. The method according to claim 8 , wherein the calcium salt is calcium chloride.
11. In a method of artificially inseminating a subject with an inseminate, the improvement comprising admixing a phosphodiesterase inhibitor and a calcium salt with the inseminate, wherein the inseminate comprising the phosphodiesterase inhibitor and the calcium salt is capable of inhibiting phagocytosis of the sperm as determined by a phagocytosis assay.
12. The method according to claim 11 , wherein the phosphodiesterase inhibitor is selected from the group consisting of caffeine, theophylline, theobromine, isobutylmethylxanthine, other xanthine based compounds, papaverine, and combinations of any thereof.
13. A method for artificially inseminating a subject, said method comprising:
obtaining an inseminate consisting essentially of sperm, an inhibitor of phosphodiesterase and a calcium salt; and
administering the inseminate to the subject.
14. The method according to claim 13 , wherein the phosphodiesterase inhibitor is selected from the group consisting of caffeine, theophylline, theobromine, isobutylmethylxanthine, other xanthine based compounds, papaverine, and combinations of any thereof.
15. The method according to claim 13 , wherein the inseminate is capable of inhibiting phagocytosis of the sperm as determined by a phagocytosis assay.
16. The method according to claim 1 , wherein the inseminate is capable of inhibiting phagocytosis of the sperm as determined by a phagocytosis assay.Join the waitlist — get patent alerts
Track US6890708B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.